Admedus sells cardio business for $36 million

Cardiovascular device manufacturer Admedus (ASX: AHZ) has sold the distribution rights to its CardioCel and VascuCel product range for $A36.2 million to LeMaitre Vascular Inc. The company, whose ADAPT engineering process produces implantable tissue bio-scaffolds for a range of cardiovascular and vascular applications, will receive $22.8 million in an upfront payment. the remainder will flow…

Cortical Dynamics may sell in South Korea

Cortical Dynamics has received regulatory approval which will lead on to an ability to sell its brain anaesthetic response monitoring (BARM) system device in South Korea. The Perth company’s Korean distributor, Globaluck, received a certificate of approval from the Korea Good Manufacturing Practice, according to an announcement by Cortical shareholder, bphenergy (ASX: BPH). The approval…

LBT Innovations wins crucial European approvals

Medical technology developer LBT Innovations (ASX: LBT) has won European CE mark certification for its APAS Independence laboratory instrument, allowing sale in all European countries. The company has identified 130 priority customers among laboratories in Europe, and will follow its successful strategy of placing its instruments with the laboratories for performance evaluation. APAS is an…